We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSKA
5401
DELISTED
Heska Corp
HSKA
$38K ﹤0.01%
365
-11
-3% -$941
CFFN icon
5402
Capitol Federal Financial
CFFN
$1.09B
$37K ﹤0.01%
2,535
-5,673
-69% -$87K
CLNE icon
5403
CALL
Clean Energy Fuels
CLNE
$427M
$37K ﹤0.01%
14,500
-41,000
-74% -$108K
CPRT icon
5404
CALL
Copart
CPRT
$27B
$37K ﹤0.01%
4,800
CPRT icon
5405
PUT
Copart
CPRT
$27B
$37K ﹤0.01%
+4,800
New +$35.3K
EBS icon
5406
Emergent Biosolutions
EBS
$373M
$37K ﹤0.01%
1,260
-3,676
-74% -$112K
EDIT icon
5407
Editas Medicine
EDIT
$396M
$37K ﹤0.01%
1,619
-487
-23% -$10.1K
FCEL icon
5408
FuelCell Energy
FCEL
$1.73B
$37K ﹤0.01%
74
+67
+957% +$37.8K
GPC icon
5409
PUT
Genuine Parts
GPC
$17.1B
$37K ﹤0.01%
400
-200
-33% -$19.2K
JDST icon
5410
CALL
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$31.6M
0
SA
5411
PUT
Seabridge Gold
SA
$2.78B
$37K ﹤0.01%
3,400
-5,800
-63% -$60.3K
ITCI
5412
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$37K ﹤0.01%
2,282
-571
-20% -$8.26K
ARAV
5413
DELISTED
Aravive, Inc. Common Stock
ARAV
$37K ﹤0.01%
289
-90
-24% -$9.49K
ENLK
5414
PUT
DELISTED
EnLink Midstream Partners, LP
ENLK
$37K ﹤0.01%
+2,000
New +$36.8K
BWP
5415
PUT
DELISTED
Boardwalk Pipeline Partners
BWP
$37K ﹤0.01%
2,000
-1,900
-49% -$34.6K
FINL
5416
CALL
DELISTED
Finish Line
FINL
$37K ﹤0.01%
2,600
-7,500
-74% -$126K
XRA
5417
DELISTED
Exeter Resources Corporation
XRA
$37K ﹤0.01%
21,400
INP
5418
DELISTED
iPath ETNs Linked to the MSCI India Total Return Index
INP
$37K ﹤0.01%
500
CCOI icon
5419
Cogent Communications
CCOI
$676M
$36K ﹤0.01%
835
-3,118
-79% -$130K
DUG icon
5420
ProShares UltraShort Energy
DUG
$20.6M
$36K ﹤0.01%
43
+34
+378% +$27.6K
FRPT icon
5421
Freshpet
FRPT
$2.93B
$36K ﹤0.01%
3,336
-771
-19% -$8.33K
HI
5422
CALL
DELISTED
Hillenbrand
HI
$36K ﹤0.01%
+1,000
New +$36.9K
IAT icon
5423
CALL
iShares US Regional Banks ETF
IAT
$674M
$36K ﹤0.01%
+800
New +$36.9K
INGR icon
5424
PUT
Ingredion
INGR
$6.27B
$36K ﹤0.01%
300
-400
-57% -$48.9K
IRM icon
5425
CALL
Iron Mountain
IRM
$36.4B
$36K ﹤0.01%
1,000
-1,500
-60% -$53.1K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.